Novel inhibition of cis/trans retinoic acid interconversion in biological fluids -: an accurate method for determination of trans and 13-cis retinoic acid in biological fluids

被引:13
|
作者
Wang, CJ
Pao, LH
Hsiong, CH
Wu, CY
Whang-Peng, JJK
Hu, OYP
机构
[1] Natl Def Med Ctr, NeiHu, Taipei 11490, Taiwan
[2] Natl Hlth Res Inst, Canc Res Ctr, Taipei, Taiwan
[3] Natl Def Med Ctr, Pharmaceut Res Inst, Taipei 11490, Taiwan
[4] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 796卷 / 02期
关键词
interconversion; pharmacokinetics; retinoic acid;
D O I
10.1016/S1570-0232(03)00572-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0 ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25 degreesC were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150 muM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000 ng/ml) and 13-cRA (5-800 ng/ml) in plasma showed good linearity (r(2) = 0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000 ng/ml and 5 to 800 ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5 ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45 mg/m(2) per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [21] Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)
    Susan E. Spiller
    Sally H. Ditzler
    Barbara J. Pullar
    James M. Olson
    Journal of Neuro-Oncology, 2008, 87 : 133 - 141
  • [22] Differences in metabolism and isomerization of all-trans-retinoic acid and 9-cis-retinoic acid between human endothelial cells and hepatocytes
    Lansink, M
    VanBennekum, AM
    Blaner, WS
    Kooistra, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (02): : 596 - 604
  • [23] The effects of 13-cis retinoic acid and interferon-α in chronic myelogenous leukemia cells in vivo in patients
    Handa, H
    Hegde, UP
    Kotelnikov, VM
    Mundle, SD
    Dong, LM
    Burke, P
    Rose, S
    Hsu, WT
    Gaskin, F
    Raza, A
    Preisler, HD
    LEUKEMIA RESEARCH, 1997, 21 (11-12) : 1087 - 1096
  • [24] INHIBITION OF LIVER MICROSOMAL LIPID-PEROXIDATION BY 13-CIS-RETINOIC ACID
    SAMOKYSZYN, VM
    MARNETT, LJ
    FREE RADICAL BIOLOGY AND MEDICINE, 1990, 8 (05) : 491 - 496
  • [25] Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial
    Veal, Gareth J.
    Tweddle, Deborah A.
    Visser, Johannes
    Errington, Julie
    Buck, Helen
    Marange, Josephine
    Moss, Jon
    Joseph, Shiju
    Mulla, Hussain
    CANCERS, 2021, 13 (08)
  • [26] Role of Chicoric Acid and 13-Cis Retinoic Acid in Mycobacterium tuberculosis Infection Control by Human U937 Macrophage
    Bahareh Abd-Nikfarjam
    Marjan Nassiri-Asl
    Mehri Hajiaghayi
    Taghi Naserpour Farivar
    Archivum Immunologiae et Therapiae Experimentalis, 2018, 66 : 399 - 406
  • [27] Role of Chicoric Acid and 13-Cis Retinoic Acid in Mycobacterium tuberculosis Infection Control by Human U937 Macrophage
    Abd-Nikfarjam, Bahareh
    Nassiri-Asl, Marjan
    Hajiaghayi, Mehri
    Farivar, Taghi Naserpour
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2018, 66 (05) : 399 - 406
  • [28] Relevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel Hydroxylation
    Rowbotham, Sophie E.
    Boddy, Alan V.
    Redfern, Chris P. F.
    Veal, Gareth J.
    Daly, Ann K.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (08) : 1261 - 1266
  • [29] A phase II pilot trial of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma
    Brembeck, FH
    Schoppmeyer, K
    Leupold, U
    Gornistu, C
    Keim, V
    Mössner, J
    Riecken, EO
    Rosewicz, S
    CANCER, 1998, 83 (11) : 2317 - 2323
  • [30] Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization
    Rühl, R
    Plum, C
    Elmazar, MMA
    Nau, H
    TOXICOLOGICAL SCIENCES, 2001, 63 (01) : 82 - 89